col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Clinical and Experimental Rheumatology

41 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―May―05 Optimising ANCA-associated vasculitis management and infectious risks during the COVID-19 pandemic Loïc Guillevin, Benjamin Terrier
2 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―May―02 Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study Greta Pellegrino, Silvia Mancuso, Tania Colasanti, Stefania Mieli, Chiara Gioia, Raffaella Izzo, et al. (+5)
3 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―13 COVID-19: the new challenge for rheumatologists. One year later Ilaria Puxeddu, Francesco Ferro, Elena Bartoloni, Elena Elefante, Chiara Baldini, Carlo Alberto Scirè, et al. (+4)
4 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―13 Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives Maurizio Benucci, Maria Infantino, Daniela Marotto, Sandro Ardizzone, Mariangela Manfredi, Piercarlo Sarzi-Puttini
5 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―12 COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave Marco Tasso, Erika Mostacciuolo, Valentina Ugoccioni, Antonio Del Puente, Rosario Peluso, Raffaele Scarpa, et al. (+2)
6 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―12 Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, José Correa-Fernández, Sergio Sanz-Gómez, Victoria Navarro-Compán
7 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―12 Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine Víctor Moreno-Torres, Ángela Gutiérrez, María Valdenebro, Alfonso Ortega, María-Jesús Cítores, Esther Montero
8 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―12 Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis Paolo Delvino, Emanuele Bozzalla-Cassione, Alessandro Biglia, Verdiana Serena Quadrelli, Alice Bartoletti, Carlomaurizio Montecucco, Sara Monti
9 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―12 Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosis Eugenia Bertoldo, Riccardo Bixio, Davide Bertelle, Denise Rotta, Ombretta Viapiana, Maurizio Rossini
10 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―12 Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosis. Reply to Bertoldo et al. Jacopo Ciaffi, Francesco Ursini
11 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―11 Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver Ioana Andreica, Robert Jast, Guenther A. Rezniczek, David Kiefer, Bjoern Buehring, Uta Kiltz, et al. (+2)
12 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 Incidence and risk factors of COVID-19 in patients with vasculitis in the first year of the pandemic: a Danish nationwide cohort study Salome Kristensen, René Cordtz, Kirsten Duch, Jesper Lindhardsen, Christian Torp-Pedersen, Lene Dreyer
13 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort Marcelo M. Pinheiro, Gecilmara S. Pileggi, Adriana M. Kakehasi, Ana Paula M. Gomides Reis, Edgard Torres Reis-Neto, Mirhelen M. Abreu, et al. (+33)
14 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome Fausto Salaffi, Valeria Giorgi, Silvia Sirotti, Sara Bongiovanni, Sonia Farah, Laura Bazzichi, et al. (+7)
15 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 Physical and mental impact of COVID-19 outbreak on fibromyalgia patients Valerie Aloush, Avital Gurfinkel, Noam Shachar, Jacob N. Ablin, Odelia Elkana
16 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis Yuta Norimatsu, Ayumi Yoshizaki, Takemichi Fukasawa, Satoshi Ebata, Koji Oba, Shinichi Sato
17 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study Javier Rivera, Isabel Castrejón, Laura Vallejo-Slocker, Martin Offenbächer, Juan Molina-Collada, Laura Trives, et al. (+7)
18 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis Cristina Iannuccelli, Bruno Lucchino, Chiara Gioia, Giulio Dolcini, Martina Favretti, Daniele Franculli, Manuela Di Franco
19 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 COVID-19 vaccine hesitancy in systemic sclerosis Jacopo Ciaffi, Dilia Giuggioli, Anna Mari, Martina D'Onghia, Amelia Spinella, Veronica Brusi, et al. (+8)
20 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―07 Systemic sclerosis and COVID-19: what's new in the literature Barbara Russo, Jennifer Ben Shimol, Marco Matucci-Cerinic, Cosimo Bruni
21 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine Shintaro Yamamoto, Keisuke Nishimura, Kohei Yo, Daisuke Waki, Hiroyuki Murabe, Toshihiko Yokota
22 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 Comment on: Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' by Giollo et al. Duriad Reffat, Magdalena Dziedzic, Ann O' Riordan, Fahd Adeeb
23 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 Prevalence and characteristics of systemic autoimmune disease-related autoantibodies in convalescent patients after SARS-CoV-2 infection Antonio Rosales-Castillo, José Mario Sabio
24 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 The impact of SARS-CoV-2 infection in children with rheumatic/autoinflammatory diseases on immunosuppressive treatment: a single centre experience Despina N. Maritsi, Panaguotis Krepis, George Vartzelis, Aggeliki Syggelou, Maria Tsolia
25 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome Irene Mattioli, Alessandra Bettiol, Elena Silvestri, Maria Letizia Urban, Adalgisa Palermo, Filippo Fagni, et al. (+4)
26 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children Ji Hee Kwak, Jong-Woon Choi, Soo-Young Lee
27 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―06 Systemic lupus erythematosus flare following SARS-CoV2 infection: the implication of IFNα and anti-IFNα autoantibodies Arthur Mageau, Pascale Nicaise Roland, Tiphaine Goulenok, Carine Farkh, Nicolas Charles, Karim Sacre
28 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus Silvia Mancuso, Francesca Romana Spinelli, Luciano Agati, Maria Rosa Ciardi, Cristina Garufi, Francesco Natalucci, et al. (+6)
29 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis Anne-Claire Desbois, Cindy Marques, Leila Lefèvre, Serge Barmo, Camille Lorenzo, Mathilde Leclercq, et al. (+7)
30 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Severity of COVID-19 infection in primary Sjögren's syndrome and the emerging evidence of COVID-19-induced xerostomia Farzana Chowdhury, Sofia Grigoriadou, Michele Bombardieri
31 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology Anna Zanetti, Greta Carrara, Gianpiero Landolfi, Davide Rozza, Cecilia Beatrice Chighizola, Alessia Alunno, et al. (+14)
32 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 High incidence of giant cell arteritis during the COVID-19 pandemic: no causal relationship but possible involvement of stress Simon Parreau, Eric Liozon, Kim-Heang Ly, Anne-Laure Fauchais, Sébastien Hantz
33 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 COVID-19 vaccination unveiling subclinical Sjögren's syndrome Manuel Ramos-Casals, Maite Sainz-de-la-Maza, Africa Muxí
34 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Henoch-Schönlein purpura with renal and gastrointestinal involvement in course of COVID-19: a case report Laura Barbetta, Giovanni Filocamo, Emanuela Passoni, Francesca Boggio, Christian Folli, Valter Monzani
35 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection Jennifer R. Hannah, Saadia Sasha Ali, Deepak Nagra, Maryam A. Adas, April D. Buazon, James B. Galloway, Patrick A. Gordon
36 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases Tali Eviatar, Victoria Furer, Ari Polachek, David Levartovsky, Ofir Elalouf, Michael Zisapel, et al. (+6)
37 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection Pilar Brito-Zerón, Nihan Acar-Denizli, Vasco C. Romão, Berkan Armagan, Raphaèle Seror, Francesco Carubbi, et al. (+18)
38 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Apr―05 Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis Salvatore Scarpato, Marco Sebastiani, Luca Quartuccio, Piero Marson, Paolo Fraticelli, Laura Castelnovo, et al. (+9)
39 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Mar―25 The decrease of Kawasaki syndrome during the second COVID-19 wave: a potential, unexpected effect of social distancing Maria Vincenza Mastrolia, Rino Agostiniani, Chiara Azzari, Roberto Bernardini, Ugo Bottone, Giovanni Battista Calabri, et al. (+19)
40 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Mar―25 Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies Gollapalle L. Viswanatha, CH.K.V.L.S.N. Anjana Male, Hanumanthappa Shylaja
41 [GO] Pathogenesis of rheumatoid arthritis one year in review 2022 2022―Mar―25 SARS-CoV-2 in the knee joint: a cadaver study Miriam Grassi, Valeria Giorgi, Manuela Nebuloni, Pietro Zerbi, Maria Rita Gismondo, Fausto Salaffi, et al. (+3)
 [1] 

41 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec